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ABSTRACT 
Azhinjiathikashayam is a herbo mineral Siddha poly herbal formulation said for the management of 
Madhumegam (Type-2 Diabetes mellitus) in ancient Siddha literature. The study drug was subjected 
to estimate the therapeutic efficacy in Madhumegam patients. A well designed study protocol was 
approve by Institutional Ethics Committee and the clinical study was conducted as an open clinical 
trial in OPD/IPD of Ayothidoss pandithar Hospital of National Institute of Siddha Chennai. 
Based on the inclusion criteria 40 Madhumegam patients (Type -2 Diabetes mellitus) were enrolled 
in this study. Informed consent was obtained from each patient before study initiation. 60ml of 
Azhinjiathikashayam was administered orally before food twice a day for a period of 90 days and 
advised to follow the prescribed dietary regimen. All the baseline data, Laboratory investigations 
were recorded in the prescribed Case Report Form of each patient. Blood sugar level in fasting and 
postprandial was done once in 30 days and HbA1c was done before treatment (0th day) and after 
treatment (90th day). The clinical assessment was recorded once in 10 days. 
Paired ‘t’ test was used to test the significance of treatment using before and after treatment data on 
HbA1c, Clinical symptoms, Blood sugar fasting and postprandial. The level of significance probability 
0.05 was used to test the treatment difference and the values are statistically significant. In this 
study there is statistically significant difference between before and after treatment on average 
HbA1c, average blood sugar of fasting and average clinical feature score (p < 0.0001). 
KEYWORDS: Madhumegam, Type -2 Diabetes mellitus, Azhinjiathikashayam, Clinical trial, Siddha 
medicine.
INTRODUCTION
In Siddha system of medicine, Madhumegam 
is a type of Meganeer which is characterized by 
passing of sweet urine as per Saint Yugi. Based on the 
derangement of three vital humours, “Meganeer” is 
classified into twenty types in which four comes 
under Vatham, six under Pitham and ten under 
Kabam. The One called Madhumegam (Honey urine) 
comes under Pitham type. According to Yugi and 
Agasthiyar, the etiology of the disease is due to life 
style changes, food and deeds Severity of the disease 
can be controlled by potent Siddha drugs with 
dietary regimen and Yoga therapy. As per Yugi 
Vaithiyachinthamani text, the signs and symptoms of 
Madhumegam is Polyuria (excessive urination), 
Polydypsia (excessive thirst), Polyphagia (excessive 
appetite), and often accompanied by unusual weight 
loss can be correlated with Type II Diabetes mellitus. 
The long term micro and macro vascular 
complications associated with Diabetes mellitus are 
responsible for a majority of its morbidity and 
mortality mentioned in modern science can also be 
correlated as well as appreciated in Yugi 
Vaithiyachinthamani under Avathaigal. 
According to International Diabetes 
Federation in 2013 globally 381 million people had 
diabetes. Its prevalence is increasing rapidly, and by 
2030, this number is estimated to almost double. 
According to the International Diabetes Foundation, 
the disease affects more than 62 million Indians, 
which is more than 7.1% of India’s adult 
population. An estimate shows that nearly 1 million 
Indians die due to Diabetes every year. The average 
age on onset is 42.5 years. The high incidence is 
attributed to a combination of genetic susceptibility 
plus adoption of a high-calorie, low-activity lifestyle 
by India's growing middle class.  
The currently available oral anti-
hyperglycemic agents for clinical use have 
characteristic profile of side effects when they 
administered regularly as a long duration. The 
management of Diabetes mellitus with agents devoid 
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of any side effects is still a challenge to the medical 
field. This had led to an increase in the demand of 
natural products with anti-hyperglycemic activity 
having fewer side effects.  
Many poly herbal formulations are being 
practiced in Siddha system of medicine in the 
treatment of Madhumegam. One such formulation is 
Azhinjiyathi Kashayam which is said for 
Madhumegam.[1] The ingredients present in this 
formulation is Phyllanthus emblica Linn, dried fruit 
(Nellimulli), Cassia auriculata Linn, Bark 
(Aavarampattai), Salacia reticulata. Wight, Bark 
(Kadalazhinjilpattai), Terminalia bellirica Roxb, Thol 
(Thandrikkaithol), Smilax china Linn, Bark (Parangi 
pattai) and Strychnos potatorum Linn.f, Seed 
(Thaetran  vithai). Literature evidences had been 
identified for the antihyperglycemic activity in each 
ingredients of this formulation.  
 When this formulation is subjected to clinical 
trial in Madhumegam (Type 2 Diabetes) patients it is 
found significant result in reducing Blood sugar level 
and also the clinical signs and symptoms of 
Madhumegam (Type 2 Diabetes). 
MATERIALS AND METHODS 
The clinical study was conducted according to 
the standard protocol, after obtaining the approval of 
the Institutional Ethical Committee (IEC) (NIS/ 
IEC/2011/3/01-24/12/2011). It is an Open Clinical 
Trial conducted in Ayothidoss Pandithar Hospital 
OPD.NO:1 Dept of Maruthuvam (Medicine), National 
Institute of Siddha, Tambaram sanatorium, Chennai.  
Subject selection 
Patients reporting at the OPD of Ayothidass 
Pandithar Hospital with symptoms of inclusion 
criteria will be subjected to screening test and 
documented by using screening proforma. After 
screening of 102 patients diagnosed as Madhumegam 
(Type 2 Diabetes mellitus), 40 cases were selected to 
this trial. Before enrollment into the trial the 
informed consent was obtained from all the study 
participants. 
Inclusion criteria 
 Age : 30-60Yrs  
 Gender: Male & Female  
 Patients with HbA1C level > 6.5%. 
 Patients who are willing to give blood sample. 
Exclusion criteria 
 IDDM (Insulin Dependent Diabetes Mellitus) 
 Cardiac disease 
 Chronic kidney diseases 
 Thyroid dysfunction 
 Gestational diabetes diseases 
Withdrawal criteria 
 Intolerance to the drug & development of any 
serious adverse reactions during drug trial. 
 Poor patient compliance & defaulters. 
 Patient turned unwilling to continue in the 
course of clinical trial. 
 Increase in severity of symptoms. 
 Uncontrolled blood sugar level 
Conduct of the study 
All the patients were given unique 
registration card in which patient’s Registration 
number of the study, Address, Phone number and 
number etc. All the baseline data, vitals, clinical signs 
and symptoms (Increased frequency of Urination 
(polyuria), Thirst (polydipsia), Excessive hunger 
(polyphagia), Body pain, Tiredness, Burning feet, 
Generalized/genital pruritis, Dull pain in the testis, 
Yellow coloured urine) and laboratory data 
(Haematology, Blood biochemistry, Lipid profile, 
LFT& RFT, HbA1c, Urine analysis and 
Ennvagaithervugal) were recorded in the Case Report 
Form (CRF) before (i.e., 0th day), commencement of 
the trial.  
The study drug packages contain 200 gms of 
Azhinjiyathi Kashayam powder sachets. Patients were 
advised to make Kashayam (10 gm powder was put 
in to 240 ml of water, then it was boiled until it 
reduces into 1/4thas Decoction) and take 60ml before 
food every day for two times for 90 days. At each visit 
(once in 10 days for 90 days) the patients were given 
the above drug packages for 10 days of treatment. At 
each visit the patients were advised to bring back the 
unconsumed drugs and return to the investigator. 
Each visit, the patient’s vitals and clinical 
assessments were recorded in the case report form 
by the investigator. Laboratory investigations were 
done at the end of the treatment.  
OBSEVATIONS  
Age group 
OP Cases Sex  Age  
30-40 41-50 51-60 
Patients Male 13 8 9 
Female 2 5 3 
Total in number and Percentage 15 (37.5%) 13 (32.5%) 12 (30%)  
The age group between 30 and 40 were 15 cases (37.5 %) between 41 and 50 were 13 cases (32.5 %) and 
between 51 and 55 were 12 cases (30 %). 
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Sex Distribution 
Patients No of cases Percentage (%) 
Male 30 75% 
Female 10 25% 
 Among 40 cases, 30 cases (75%) were Male and 10 cases (25%) were Female.  
Educational Status 
Education status No of cases Percentage (%) 
Illiterate 14 35 
Literate 26 65 
14 patients (35 %) were Illiterate, 26 patients (65 %) were Literate. 
Occupation Status 
Occupation No of cases Percentage (%) 
Driver 5 12.5 
Business man 16 40 
House wife 10 25 
Post man 2 5 
Manual workers 7 17.5 
Among 40 cases 5 patients (12.5 %) were Drivers, 16 patients (40 %) were Business man, 10 cases (25 %) 
were House wives, 2 patients (5 %) were Post men, and 7patients (17.5 %) were Manual workers. 
Marital Status 
Marital status No of cases Percentage (%) 
Unmarried 3 7.5 
Married 37 92.5 
Out of 40 cases 3 patients (8 %) were Unmarried, 37 patients (92.5 %) were married. 
Socio- Economic Status  
S.No Economic status No of cases Percentage (%) 
1. Poor 8 20 
2. Middle class 26 65 
3. Rich 6 15 
Among 40 patients, 8 cases (20 %) were under poor socio- economic status and 26 cases (65 %) were from 
middle class family and 6cases (15 %) were from upper class. 
 Menopausal Status 
Menopause No of cases Percentage (%) 
Not yet attained 6 60 
Attained 4 40 
Among 10 female study participants, 6 patients (60 %) were not yet attained menopause and 4 (40 %) patients 
were Attained menopause.  
Family History 
Family history No of cases Percentage (%) 
Family history 22 55 
No family history 18 45 
Among 40 Patients,18 cases (45%) had positive family history of type 2 diabetes.  
Personal Habits 
Personal habits No of cases Percentage (%) 
Smokers 6 15% 
Alcoholic 12 30% 
Non smokers & Non Alcoholic 22 55% 
 15% of patients (6) were smokers, 30% (12) patients were alcoholic, and 55% (22) cases were Non 
smokers & Non Alcoholic.  
Food Habits 
Food habits No of patients Percentage (%) 
Vegetarian 10 25 
Non vegetarian 30 75 
75% of cases were Non vegetarians and 25 % were vegetarians. 
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Duration of Illness 
Fig.1 
 
Among the 40 known diabetic patients,18 (45 %) cases were diabetic within 1 year. 15 (37.5 %) 
patients were between 1and 3 years and 5 (12.5 %) patients were between 3and 5 years and 2 (5 %) patients 
were between 5 and 10 years. 
Clinical signs and symptoms 
 Among 40 cases, during 1st visit, polyuria was in 20 cases (50 %), Polydypsia in 40 cases (16 %), 
polyphagia in 15 cases (37.5 %), nocturia in 12 cases (30 %), Tiredness in 28 cases (70%) Body pain in 12 
cases (305 %), Wight gain in 6 cases (15 %), pain and burning sensation of sole in 6 case (15 %) and pruritis in 
genitals in 1 case (2.5%). 
RESULTS 
Table 1: Clinical symptoms of Madhumegam before treatment and after treatment 
 
Clinical features 
No of cases Improvement (%) 
Before 
treatment 
After 
treatment 
Before 
treatment 
After 
treatment 
Polyurea 37 20 92.5 50 
Nocturia 32 12 80 30 
Polydipsia 28 16 70 40 
Polyphagia 30 15 75 37.5 
Body pain 28 12 70 30 
Weight gain 6 2 15 5 
Tiredness 38 28 95 70 
Burning feet 16 6 40 15 
Genital pruritus 5 1 10 2.5 
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Table 2: Gradation Of Results 
S.No. Gradation of results No of cases Percentage (%) 
1. Good 20 50 
2. Moderate 10 25 
3. Poor 10 25 
Total  40 100 
 
 
Inference 
Diagram shows that 50% (20) of cases had good control, 25% (10) of cases had moderate and 25% 
(10) of cases had poor control. 
Good control: HbA1c - 6.1%-7%%. (20 cases i.e., 50%) 
Moderate control: HbA1c- 7.1%-8% (10 cases i.e., 25%) 
Poor control: HbA1c- >8% (10 cases i.e., 25%) 
Statistical Analysis 
All collected data were entered into computer using MS Excel software. The data entry was cross-
checked manually with CRF. The data was analyzed using SPSS version 18.0 software. The probability value 
0.05 was taken as significant level. Paired ‘t’ test was employed to determine the significance of blood sugar at 
before and after treatment. 
Table 3: Mean ± Standard deviation of HbA1c - Before and after treatment 
Treatment status Mean ±Std deviation Significance 
HbA1c – before 8.39 ±1.41 t = 11.4, p <0.0001 
Significant HbA1c – after 7.45 ±1.24 
The average HbA1c at the start of treatment and after the treatment were 8.39 and 7.45 respectively 
and it is significant. 
Table 4: Mean ± Standard deviation of Blood sugar at FA- Before and after treatment 
Treatment status Mean ±Std deviation Significance 
FA – before 162.15 ±48.11 t = 2.6002, p <0.0128 
Significant FA – after 147.74 ±40.92 
The average blood sugars (FA) at the start of treatment and after the treatment were 162.15 and 147.74 
respectively and it is significant. 
Table 5: Mean ± Standard deviation of Blood sugar at PP- Before and after treatment 
Treatment status Mean ±Std deviation Significance 
PP – before 248.35 ± 59.86 t = 0.560, p =0.058 
 PP – after 244.75±66.24 
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 The average blood sugars (pp) at the start of treatment and after the treatment were 248.35 and 244.75 
respectively.  
Table 6: Mean ± Standard deviation of clinical feature score - Before and after treatment 
Treatment status Mean ±Std deviation Significance 
Clinical feature – before 5.37 ±1.49 t = 8.411, p <0.0001 
Significant Clinical feature– after 3.47 ±1.46 
 The average clinical feature score at the start 
of treatment and after the treatment were 5.37 and 
3.47 respectively and it is significant. 
There is statistically significant difference 
between before and after treatment on average 
HbA1c, average blood sugar of FA and average 
clinical feature score (p<0.0001). 
DISCUSSION 
Diabetes is a common disease, with major 
global health consequences. World wide prevalence 
is expected to increase 300 million people by 2025; 
90% of these people will have type 2 diabetes. It is 
the most common type of diabetes representing 
about 85% of cases in most caucasion populations 
and western countries, but more than 95% of 
diabetes in developing countries.[2]India is now the 
country with the most diabetic people, and Indian 
migrants in many parts of the world have a higher 
frequency of diabetes than the indigenous population 
has. 
 There has been a progressive rise in the 
prevalence of diabetes in India since the 1970s, with 
increase from about 2% to 12% in urban populations. 
In many regions, diabetes is more common in urban 
than in rural populations. Type 2 Diabetes is usually a 
disease of the middle aged or elderly. Most subjects 
are diagnosed after the age of 40 years, the peak age 
of onset in developing countries being about 60 - 70 
years. 
Various clinical risk factors are associated 
with the disease, such as increasing age, obesity, 
physical inactivity a family history of diabetes and 
racial and geographical variations in the frequency. 
Social deprivation, unemployment and poverty in city 
dwellers may cosegregate with diabetogenic lifestyle 
factors, such as decreased physical activity, 
westernized diet and obesity.  
Obesity contributes to diabetes by causing 
insulin resistance, the best relationship being with 
the amount of visceral fat. About 80% of type 2 
diabetic patients are obese. Obesity and under 
activity are maior risk factors for developing this type 
of diabetes. A BMI >35 KG/M2 increases the risk of 
type 2 diabetes developing over a 10 year period by 
80 fold, as compared with those with a BMI <22 
kg/m2. type 2 diabetes is now becoming a problem in 
children with an increasing frequency in many 
countries that is paralleled by the increase in ors, 
though many have positive family history of type 2 
diabetes.  
Irrespective of personal habits the disease 
affects all groups such as smokers, alcoholic, non 
smokers and non alcoholic. Cigarette smoking 
markedly enhances CVD risk in diabetes and should 
be discouraged vigorously. Stoping smoking is at 
least as effective in reducing CVD in diabetes as 
reducing cholesterol and controlling blood pressure 
and glycaemic. Regular exercise can reduce long –
term mortality by 50-60% in type2 diabetic people 
compared with patients with poor cardio respiratory 
fitness.In long duration type 1 diabetes nephropathy 
and heart disease are common, whereas in type 2 
diabetes most deaths are due to cardio vascular 
disease. 
Glycated haemoglobin percentage is a 
measure of integrated glycaemic control over the 
preceding 2 -3 months, and especially the last month. 
In clinical practice, HbA1c provides a objective 
measure of long term glycaemic control in a single 
measurement. 
The ingredients of Azhinjiyathi Kashayam 
namely Phyllanthus emblica Linn, dried fruit 
(Nellimulli), Cassia auriculata. Linn, Bark 
(Aavarampattai), Salacia reticulata. Wight, Bark 
(Kadalazhinjilpattai), Terminalia bellirica Roxb, Thol 
(Thandrikkaithol), Smilax china Linn, Bark (Parangi 
pattai) and Strychnos potatorum. Linn.f, Seed 
(Thaetran vithai), have been identified for the 
antihyperglycemic activity in various research 
articles. Phyllanthus emblica possesses anti-oxidant, 
hypoglycaemic, antihyperlipedimic effects. 
Chandrashekar CN, et al[3] reported that Salacia 
rticulata extract of bark or core root alone are more 
effective in decreasing blood glucose level in alloxan 
induced diabetic rats. In vitro studies confirmed 
scavenging activity of free radicals, superoxide and 
hydrogen peroxide. Oral administration of 
methanolic extract of Cassia auriculata bark of 250 
mg/kg showed a significant reduction was observed 
in the blood glucose level of streptozotocin induced 
diabetic rats[4]. 
Mahendra Shiradkar et al[5] reported that, the 
methanolic extract of Cassia auriculata bark were 
found to posses promisinganti-diabetic, 
antimutagenic and anti-fertility activities in 
streptozotocin induced diabetic rats. Terminalia 
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bellirica extract (100mg/kg, body weight) 
significantly decreased serum glucose level in 
hyperglycaemic animals[6]. The hydro alcoholic and 
aqueous extract of Smilax china Linn (1g/kg) 
produces a significant reduction in blood glucose 
levels in alloxon- induced diabetic rats[7]. Biswas A 
et.al[8] evaluated the antidiabetic effect of seeds of 
Strychnospotatorum Linn. in a model of diabetes 
mellitus using streptozotocin (40 mg/kg b.w., i.p.). 
The antidiabetic effects were compared with glipizide 
as the reference hypoglycemic drug. Strychnos 
potatorum Linn. (100 mg/kg p.o.) Significantly 
reduced fasting blood sugar, the effects being 
comparable with glipizide (40 mg/kg, p.o.), an 
established hypoglycemic drug. The anti diabetic 
effect of each ingredient in this formulation is due the 
presence of potent pyhtoconstituents.  
CONCLUSION 
 In this clinical study, the Siddha medicine 
Azhinjiyathikashayam a poly herbal formulation was 
effective in reducing the Blood sugar level in 
Madhumegam (Type-2 diabetes) patients, and did not 
produce any adverse drug reactions during long term 
administration in diabetes patients. This may also 
prevent the development of complications in 
Diabetes as the drug is purely a herbal based 
medicine and it is safe to administer in chronic cases. 
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